Interventional Cardiology
CAD diagnosis, treatment, and outcomes
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does bio-statin vs placebo improve outcomes in Coronary Artery Disease?
Low Certainty+ Favors benefitbio-statin vs placebo · Cardiac Output
Does liraglutide vs metformin improve outcomes in Diabetes Mellitus, Type 2?
Low Certainty+ Favors benefitliraglutide vs metformin · Cardiac Output
Does clopidogrel vs aspirin improve Cardiac Output in Coronary Artery Disease?
Low Certainty+ Favors benefitclopidogrel vs aspirin · Cardiac Output
Does atorvastatin vs placebo improve outcomes in Stroke?
Low Certainty+ Favors benefitatorvastatin vs placebo · Stroke Hospitalization
Does aspirin vs placebo improve outcomes in Acute Coronary Syndrome?
Low Certainty− Favors harmaspirin vs placebo · Cardiac Output
Does clopidogrel vs placebo improve outcomes in Coronary Artery Disease?
Low Certainty− Favors harmclopidogrel vs placebo · Cardiac Output
Does everolimus vs placebo improve outcomes in multivessel coronary artery disease?
Low Certainty− Favors harmeverolimus vs placebo · Cardiac Output
Does clopidogrel vs aspirin improve outcomes in Coronary Artery Disease?
Low Certainty− Favors harmclopidogrel vs aspirin · Cardiac Output
Does bio-statin vs placebo improve outcomes in Acute Coronary Syndrome?
Low Certainty− Favors harmbio-statin vs placebo · Cardiac Output
Coronary artery disease (also known as CAD, coronary disease, ischemic heart disease). CAD diagnosis, treatment, and outcomes
Synapse tracks 9 specific clinical questions in Coronary artery disease, each synthesized independently from its own trial evidence. They include: "Does bio-statin vs placebo improve outcomes in Coronary Artery Disease?"; "Does liraglutide vs metformin improve outcomes in Diabetes Mellitus, Type 2?"; "Does clopidogrel vs aspirin improve Cardiac Output in Coronary Artery Disease?"; "Does atorvastatin vs placebo improve outcomes in Stroke?"; "Does aspirin vs placebo improve outcomes in Acute Coronary Syndrome?".
As of 2026-06-25, the scientific consensus on Coronary artery disease is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/69b0a30cb42209bc31dca33b.
Deterministic synthesis from Synapse's enriched corpus — 128 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Coronary artery disease paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Coronary artery disease papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers